Effects by periodontitis on pristane-induced arthritis in rats

被引:13
|
作者
Eriksson, Kaja [1 ]
Lonnblom, Erik [2 ]
Tour, Gregory [1 ,3 ]
Kats, Anna [1 ]
Mydel, Piotr [4 ]
Georgsson, Pierre [1 ]
Hultgren, Catharina [3 ]
Kharlamova, Nastya [5 ]
Norin, Ulrika [2 ]
Jonsson, Jorgen [1 ]
Lundmark, Anna [1 ]
Hellvard, Annelie [4 ,6 ]
Lundberg, Karin [5 ]
Jansson, Leif [1 ,7 ]
Holmdahl, Rikard [2 ,8 ]
Yucel-Lindberg, Tulay [1 ]
机构
[1] Karolinska Inst, Div Periodontol, Dept Dent Med, Box 4064, S-14104 Huddinge, Sweden
[2] Karolinska Inst, Sect Med Inflammat Res, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden
[3] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Alfred Nobels Alle 8, S-14183 Huddinge, Sweden
[4] Univ Bergen, Dept Clin Sci, Broegelmann Res Lab, Lab Bldg,5th Floor, N-5021 Bergen, Norway
[5] Karolinska Univ Hosp, Dept Med, Rheumatol Unit, Rheumatol Clin D2 01, S-17176 Stockholm, Sweden
[6] Jagiellonian Univ, Malopolska Ctr Biotechnol, Gronostajowa 7a, PL-30387 Krakow, Poland
[7] Stockholm Cty Council, Dept Periodontol, Eastmaninst, Dalagatan 11, S-11324 Stockholm, Sweden
[8] Southern Med Univ, Ctr Med Immunopharmacol Res, Guangzhou, Guangdong, Peoples R China
基金
英国医学研究理事会; 瑞典研究理事会;
关键词
Arginine gingipain; Citrullinated peptide; Cytokine; Inflammation; Peptidylarginine deiminase; Periodontitis; Pristane-induced arthritis; Porphyromonas gingivalis; MAJOR HISTOCOMPATIBILITY COMPLEX; EARLY RHEUMATOID-ARTHRITIS; ACUTE-PHASE PROTEINS; PORPHYROMONAS-GINGIVALIS; CITRULLINATED PROTEINS; POSITIONAL IDENTIFICATION; IMMUNE-RESPONSE; DISEASE; AUTOIMMUNITY; PATHOGENESIS;
D O I
10.1186/s12967-016-1067-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: An infection-immune association of periodontal disease with rheumatoid arthritis has been suggested. This study aimed to investigate the effect of pre-existing periodontitis on the development and the immune/inflammatory response of pristane-induced arthritis. Methods: We investigated the effect of periodontitis induced by ligature placement and Porphyromonas gingivalis (P. gingivalis) infection, in combination with Fusobacterium nucleatum to promote its colonization, on the development of pristane-induced arthritis (PIA) in rats (Dark Agouti). Disease progression and severity of periodontitis and arthritis was monitored using clinical assessment, micro-computed tomography (micro-CT)/intraoral radiographs, antibody response, the inflammatory markers such as alpha-1-acid glycoprotein (alpha-1-AGP) and c-reactive protein (CRP) as well as cytokine multiplex profiling at different time intervals after induction. Results: Experimentally induced periodontitis manifested clinically (P < 0.05) prior to pristane injection and progressed steadily until the end of experiments (15 weeks), as compared to the non-ligated arthritis group. Injection of pristane 8 weeks after periodontitis-induction led to severe arthritis in all rats demonstrating that the severity of arthritis was not affected by the pre-existence of periodontitis. Endpoint analysis showed that 89% of the periodontitis- affected animals were positive for antibodies against arginine gingipain B and furthermore, the plasma antibody levels to a citrullinated P. gingivalis peptidylarginine deiminase (PPAD) peptide (denoted CPP3) were significantly (P < 0.05) higher in periodontitis rats with PIA. Additionally, there was a trend towards increased pro-inflammatory and anti-inflammatory cytokine levels, and increased a-1-AGP levels in plasma from periodontitis-challenged PIA rats. Conclusions: Pre-existence of periodontitis induced antibodies against citrullinated peptide derived from PPAD in rats with PIA. However, there were no differences in the development or severity of PIA between periodontitis challenged and periodontitis free rats.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Mechanical hyperalgesia is attenuated by local administration of octreotide in pristane-induced arthritis in Dark-Agouti rats
    Yao, FanRong
    Guo, Yuan
    Lu, SheMin
    Sun, ChengWen
    Zhang, Qi
    Wang, HuiSheng
    Zhao, Yan
    LIFE SCIENCES, 2008, 83 (21-22) : 732 - 738
  • [32] miRNA Expression and Interaction with Genes Involved in Susceptibility to Pristane-Induced Arthritis
    Fernandes, Jussara Goncalves
    Borrego, Andrea
    Jensen, Jose Ricardo
    Koury Cabrera, Wafa Hanna
    Correa, Mara Adriana
    Starobinas, Nancy
    Ribeiro, Orlando Garcia
    Ibanez, Olga Martinez
    De Franco, Marcelo
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [33] Different therapeutic and bystander effects by intranasal administration of homologous type II and type IX collagens on the collagen-induced arthritis and pristane-induced arthritis in rats
    Lu, SM
    Holmdahl, R
    CLINICAL IMMUNOLOGY, 1999, 90 (01) : 119 - 127
  • [34] B- and T-cell autoantigens in pristane-induced arthritis
    Barker, RN
    Easterfield, AJ
    Allen, RF
    Wells, AD
    Elson, CJ
    Thompson, SJ
    IMMUNOLOGY, 1996, 89 (02) : 189 - 194
  • [35] PRISTANE-INDUCED LUPUS IN BALB/C MICE: A MODEL FOR LUPUS ARTHRITIS
    Leiss, H.
    Niederreiter, B.
    Bandur, T.
    Blueml, S.
    Steiner, G.
    Smolen, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 527 - 527
  • [36] Pristane-induced arthritis is characterized by broad reactivity to joint antigens.
    Morgan, RA
    Song, Z
    Wu, B
    Wooley, PH
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S299 - S299
  • [37] Modulation of T cell responses with IL-12: Effects on pristane-induced arthritis.
    Siew, LK
    Beech, JT
    Elson, CJ
    Thompson, SJ
    IMMUNOLOGY, 1996, 89 : BB311 - BB311
  • [38] Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats
    Lena Wester
    Dirk Koczan
    Jens Holmberg
    Peter Olofsson
    Hans-Jürgen Thiesen
    Rikard Holmdahl
    Saleh Ibrahim
    Arthritis Res Ther, 5
  • [39] IMMUNOTHERAPY OF PRISTANE-INDUCED ARTHRITIS USING ANTI-CD4 ANTIBODIES
    LEVITT, NG
    FERNANDEZMADRID, F
    WOOLEY, PH
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S193 - S193
  • [40] Rats congenic for the chromosome 2 locus Cia10 are significantly protected in pristane-induced arthritis.
    Brenner, M
    Meng, HC
    Yarlett, N
    Remmers, EF
    Wilder, RL
    Gulko, PS
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S546 - S547